The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Open accessAbstract
BACKGROUND: Chronic human immunodeficiency virus (HIV) infection is associated with intestinal permeability and microbial translocation that contributes to systemic immune activation, which is an independent predictor of HIV disease progression. The association of microbial translocation with clinical outcome remains unknown. METHODS: This nested case-control study included 74 subjects who died, 120 of whom developed cardiovascular disease and 81 of whom developed AIDS during the Strategies for Management of Anti-Retroviral Therapy (SMART) study with matched control subjects. Intestinal fatty acid binding protein (I-FABP), lipopolysaccharide (LPS), soluble CD14 (sCD14), endotoxin core antibody (EndoCAb), and 16S ribosomal DNA (rDNA) were measured in baseline plasma samples. RESULTS: Subjects with the highest quartile of sCD14 levels had a 6-fold higher risk of death than did those in the lowest quartile (95% confidence interval, 2.2-16.1; P<.001), with minimal change after adjustment for inflammatory markers, CD4(+) T cell count, and HIV RNA level. No other marker was significantly associated with clinical outcomes. I-FABP, LPS, and sCD14 were increased and EndoCAb was decreased in study subjects, compared with healthy volunteers. sCD14 level correlated with levels of IL-6, C-reactive protein, serum amyloid A and D-dimer. CONCLUSIONS: sCD14, a marker of monocyte response to LPS, is an independent predictor of mortality in HIV infection. Therapeutic attenuation of innate immune activation may improve survival in patients with HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, as among those without HIV infection, a likely driving force behind this vulnerability to injury is chronic inflammation (67–69).”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citationCD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836
Self-citation. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citationVeazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404
LPS, TLR4 and infectious disease diversity
Miller, S., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 1,059
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Self-citationDeeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803
Self-citationJiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598
Self-citation
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Hale, A. T., Longenecker, C. T., Jiang, Y., Debanne, S. M., Labbato, D. E., Storer, N. J., Hamik, A., & McComsey, G. A. (2015) · AIDS · doi:10.1097/qad.0000000000000756 · Cited by 3
LEVELS OF PLASMA SOLUBLE CD14 IN HIV-INFECTED OPIATE USERS
Кholodnaya, A. N., Lioznov, D. A., Blokhina, E. A., Yaroslavtseva, T. V., & Krupitsky, E. M. (2018) · Journal Infectology · doi:10.22625/2072-6732-2018-10-1-47-54 · Cited by 3
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection
Iannetta, M., Isnard, S., Manuzak, J. A., Guillerme, J.-B., Notin, M., Bailly, K., Andrieu, M., Amraoui, S., Vimeux, L., Figueiredo, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01658 · Cited by 4
Llibre, J. M., Cahn, P. E., & Barber, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904689 · Cited by 3
S100A9 interacts with a dynamic region on CD14 to activate Toll-like receptor 4Preprint
Chisholm, L. O., Jaeger, N. M., Murawsky, H. E., & Harms, M. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594416 · Cited by 3
Fulcher, J. A., Newman, K., Pham, B., Li, D., Cho, G. D., Elliott, J. E., Tobin, N. H., SHOPTAW, S. J., Gorbach, P. M., & Aldrovandi, G. M. (2026) · mSphere · doi:10.1128/msphere.00384-26 · Cited by 2
Increased IFN responses drive myeloid cell activation in people living with HIV-1
Plaçais, L., Joly, C., D’Urbano, V., Paolini, A., Bitu, M., Mouanga, C., Bourdic, K., Desjardins, D., Bredel, D., Bourdic, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-04613-0 · Cited by 6
Ageing with HIV-1: immunological challenges for effective vaccination
Saint-Charles, P., Didierlaurent, A. M., & Appay, V. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00544-6 · Cited by 2
Transcriptional Changes in CD8+ T Cells During Antiretroviral Therapy Intensified With Raltegravir
Ouyang, Z., Buzón, M. J., Zheng, L., Sun, H., Yu, X. G., Bosch, R. J., Mellors, J. W., Eron, J. J., Gandhi, R. T., & Lichterfeld, M. D. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv045 · Cited by 2
Seu, L., Ortiz, G. M., Burt, T. D., Deeks, S. G., Martin, J. N., & McCune, J. M. (2014) · AIDS Research and Therapy · doi:10.1186/1742-6405-11-27 · Cited by 2
Self-citationImmune correlates of cardiovascular co-morbidity in HIV infected participants from South India
Kausalya, B., Saravanan, S., Pallikkuth, S., Pahwa, R., Saini, S. R., Iqbal, H. S., Solomon, S. S., Murugavel, K. G., Poongulali, S., Kumarasamy, N., et al. (2022) · BMC Immunology · doi:10.1186/s12865-022-00498-0 · Cited by 2
Gong, K., & Lai, Y. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03624-7 · Cited by 2
Rahmawati, N. Y., Ahsan, F., Santoso, B. I., Mufid, A. F., Sa’adi, A., Dwiningsih, S. R., Tunjungseto, A., & Widyanugraha, M. Y. A. (2024) · Gynecologic and Obstetric Investigation · doi:10.1159/000538525 · Cited by 2
Nemphos, S. M., Green, H. C., Prusak, J. E., Fell, S. L., Goff, K. A., Varnado, M., Didier, K., Guy, N., Moström, M. J., Tatum, C., et al. (2024) · Viruses · doi:10.3390/v16071036 · Cited by 2
Cytokine trajectory over time in men and women with HIV on long-term ART
Vanpouille, C., Wells, A. H., DeGruttola, V. G., Lynch, M. L., Zhang, X., Fitzgerald, W., Tu, X. M., Chaillon, A., LANDAY, A. L., Weber, K. M., et al. (2024) · AIDS · doi:10.1097/qad.0000000000004033 · Cited by 2
Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV
Izquierdo, R., Vallejo, A., Suárez‐García, I., Martín-Hondarza, A., Gutiérrez, F., Pérez-Molina, J. A., García, D. V., Macı́as, J., Rivero, A., Olalla, J., et al. (2025) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003667 · Cited by 3
Clinical and experimental treatment of residual immune activation in people living with HIV
Nganou‐Makamdop, K. (2025) · Clinical & Experimental Immunology · doi:10.1093/cei/uxaf023 · Cited by 2
Freer, G. B., Cooper, J. M., Nirantharakumar, K., Thomas, G. N., & Gooden, T. E. (2025) · HIV Medicine · doi:10.1111/hiv.70044 · Cited by 2
Gáspár, Z., & Lakatos, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136366 · Cited by 2
Estébanez, M., Stella-Ascariz, N., & Bernardino, J. I. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2011.11.010 · Cited by 2
Pathophysiologic Mechanisms of Immune-mediated Drug Hypersensitivity Reactions to Sulfonamides
Sultan, E. A. (2015) · Scholarship@Western (Western University) · Cited by 2
Fantauzzi, A., Falasca, F., d’Ettorre, G., Cavallari, E. N., Turriziani, O., Vullo, V., & Mezzaroma, I. (2013) · IRIS Research product catalog (Sapienza University of Rome) · doi:10.5495/wjcid.v3.i4.47 · Cited by 2
Vinnard, C., Manley, I., Scott, B. N. V., Bernui, M., Adams, J. W., Varghese, S., Zentner, I., & Kutzler, M. A. (2017) · Tuberculosis Research and Treatment · doi:10.1155/2017/2140974 · Cited by 2
Kantamala, D., Praparattanapan, J., Taejaroenkul, S., Srithep, S., Yoosupap, R., & Supparatpinyo, K. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155257 · Cited by 2
Lange, C., & Maldarelli, F. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab565 · Cited by 2
Melo, M. B. G., Cunha, L. C. S., Passos, C. S., de Mendonça, F. A. O., Santos, M. L. B., Sacramento, D., de Jesus, A. R., de Almeida, R. P., & dos Santos, P. L. (2021) · Parasitology Research · doi:10.1007/s00436-021-07258-w · Cited by 2
Emerging risk factors for QT interval prolongation and torsades de pointes
Lazzerini, P. E., Pasini, F. L., Capecchi, P. L., & Boutjdir, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821446-6.00009-2 · Cited by 2
Zhang, G., Wu, R.-D., Zheng, H., Zhang, X.-L., Zhang, M., Tian, R., Liu, G., Pang, W., & Zheng, Y. (2015) · Journal of Immunology Research · doi:10.1155/2015/202738 · Cited by 2
Babu, H., Ambikan, A. T., Gabriel, E. E., Akusjärvi, S. S., Natarajan, A. P., Sundaraj, V., Mupanni, N. R., Sperk, M., Cheedarla, N., Sridhar, R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/418012 · Cited by 2
Patel, M., Singh, S., Davidow, A. L., Dai, J., & Fitzgerald-Bocarsly, P. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.05.498853 · Cited by 2
Coronary heart disease in patients with human immunodeficiency virus infection
Alieva, A. M., Batov, M. A., Skripnichenko, E. A., Teplova, N. V., Baykova, I. E., Valiev, R. K., Фатхуллаевна, А. М., Kotikova, I. A., Алмардонович, М. А., & Nikitin, I. G. (2023) · Russian Medicine · doi:10.17816/medjrf112317 · Cited by 1
Neelamegam, M., Nawi, N., Bashah, N. S. A., Yap, S. H., Zulhaimi, N. S., Kamarulzaman, A., Kamaruzzaman, S. B., Ramli, N. M., & Rajasuriar, R. (2023) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1251126 · Cited by 1
Evolving biomarkers for HIV-associated neurocognitive disorders (HAND)
Pulliam, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00038-9 · Cited by 1
Savinelli, S., McGettrick, P., Leon, A. A. G., Tinago, W., Haran, E., Barco, E. Á., LANDAY, A. L., Mallon, P. W. G., Feeney, E. R., & Study, O. B. O. T. A. I. I. D. C. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003508 · Cited by 1
Perspective: clinical relevance of epigenetic aging and HIV
Schoepf, I. C., Haerry, D., Esteban-Cantos, A., Arribas, J. R., TARR, P. E., & Study, T. S. H. C. (2025) · Epigenomics · doi:10.1080/17501911.2025.2491299 · Cited by 1
Brief Report: Sex and HIV Modify Immune Activation Biomarkers in Ugandans Post-Tuberculosis
Abelman, R. A., Fitzpatrick, J., Zawedde, J., Beck‐Engeser, G., Sanyu, I., Marzan, F., Byanyima, P., Ambayec, G. C., Kaswabuli, S., Musisi, E., et al. (2025) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003713 · Cited by 1
Pathogenic SIV infection is associated with acceleration of epigenetic age in rhesus macaques
Jasinska, A. J., Sivanandham, R., Sivanandham, S., Xu, C., Gordevičius, J., Milčiūtė, M., Brooke, R. T., Sette, P., He, T., Brocca‐Cofano, E., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci189574 · Cited by 1
Schroeder, T. A., Manuzak, J. A., Miller, C. J., Gustin, A. T., Basting, C. M., Cheu, R. K., Velez, A., Driscoll, C. B., Tisoncik-Go, J., Schifanella, L., et al. (2025) · Journal of Virology · doi:10.1128/jvi.01003-25 · Cited by 5
Yunihastuti, E., Ophinni, Y., Sari, V., Adli, I., Yamada, C., Widhani, A., Sanityoso, A., & Gani, R. A. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70627 · Cited by 1
Fu, T., Francis, E. C., Kinkade, C. W., SPERLING, R. S., Qiu, Y., Kurland, I. J., Jao, J. K., & Shiau, S. (2025) · Metabolites · doi:10.3390/metabo15120765 · Cited by 1
The role of pyroptosis during HIV infection
Yaseen, M. M., Abuharfeil, N. M., Darmani, H., & Shatnawi, M. (2026) · Inflammation Research · doi:10.1007/s00011-025-02164-8 · Cited by 1
HIV reservoir dynamics according to the timing of antiretroviral therapy initiation or modification
Gantner, P., Cheneau, C., Kowalczyk, J., Faller, J.-P., Martinot, M., Mosheni-Zadeh, M., Fuchs, A., Rey, D., & Fafi‐Kremer, S. (2026) · Infectious Diseases Now · doi:10.1016/j.idnow.2026.105264 · Cited by 1
Rallón, N. I., Restrepo, C., Manquillo, A., Pérez‐Sánchez, C., Mahillo, I., Nistal, S., Al‐Hayani, A., Cabello, A., Carrillo-Acosta, I., Prieto, L., et al. (2026) · Journal of Medical Virology · doi:10.1002/jmv.70901 · Cited by 1
Monocyte Dll4 Contributes to Systemic Inflammation in People Living With HIV
Wang, S., Singh, M. V., Morrell, C. N., Yang, H., Rhen, J. M., Wang, T., Mohamad, L. A., Xu, J. J., Nguyen, T., Ture, S. K., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.326836 · Cited by 5
Abad-Fernández, M., Gutiérrez, C., Madrid, N., Hernández‐Novoa, B., Díaz, L., Muñoz‐Fernández, M. Á., Moreno, S., & Vallejo, A. (2014) · HIV Medicine · doi:10.1111/hiv.12167 · Cited by 1
Lin, T., Lin, F., Hung, C.-C., Liu, C., Hsiao, Y.-C., Lee, C.-H., & Wang, N. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.05.001 · Cited by 1
Dubé, M. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-11161-2_14 · Cited by 1
Johnston, D. G. W., Hambly, R., Kearney, N., Tobin, D. J., & Kirby, B. (2022) · HRB Open Research · doi:10.12688/hrbopenres.13633.1 · Cited by 1
Maramba, A. (2024) · Haematology International Journal · doi:10.23880/hij-16000228 · Cited by 1
Louis, I. V.-S., & Mohei, H. (2024) · Diseases · doi:10.3390/diseases12050101 · Cited by 2
Baissary, J., Koberssy, Z., Wu, Q., Sattar, A., Atieh, O., Daher, J., Ailstock, K., Cummings, M. J., Labbato, D. E., Funderburg, N., et al. (2025) · Nutrients · doi:10.3390/nu17101671 · Cited by 1
Chachage, M., & Geldmacher, C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1489-0_6 · Cited by 2
CROI 2014: Viral hepatitis and complications of HIV disease and antiretroviral therapy.
Luetkemeyer, A. F., Havlir, D. V., & Currier, J. S. (2014) · Europe PMC (PubMed Central) · Cited by 1
Leaky gut, clotting, and vasculopathy in SIV
Hunt, P. W. (2012) · Blood · doi:10.1182/blood-2012-06-435115 · Cited by 1
López, M. T. R., Oyuela, S. M., Castro-Torres, G. A., & Jaimes, F. A. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.05.012 · Cited by 1
Microbial Translocation and the Effects of HIV/SIV Infection on Mucosal Barrier Function
Epple, H., Schneider, T., & Zeitz, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00077-x · Cited by 1
Aging With HIV and Oxidative Stress
Motta, I., & Calcagno, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809853-0.00004-3 · Cited by 1
ASSESSMENT OF SYSTEMIC INFLAMMATION MARKERS IN HIV INFECTED OPIATE USERS
Николаевна, Х. А., Lioznov, D. A., Леонидовна, Н. С., Blokhina, E. A., Yaroslavtseva, T. V., & Krupitsky, E. M. (2018) · HIV Infection and Immunosuppressive Disorders · doi:10.22328/2077-9828-2018-10-2-90-95 · Cited by 1
Immune Disorders in HIV-Infected Patients Coinfected with Hepatitis C Virus
Владимирович, Ш. К., & Сайдакова, Е. В. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.76810 · Cited by 1
Dou, Y., van Montfoort, N., van den Bosch, A., Janssen, H. L. A., de Man, R. A., Buschow, S. I., & Woltman, A. M. (2019) · Journal of Viral Hepatitis · doi:10.1111/jvh.13127 · Cited by 1
Brun, V. L., Corbel, A., Hsing, A. W., Kemp, T. J., Dyke, A. L. V., Hildesheim, A., Zhu, B., Gao, Y., Pinto, L. A., & Koshiol, J. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-92728-5 · Cited by 1
Borato, D. C. K., & Vellosa, J. C. R. (2020) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902019000318567 · Cited by 1
Wohl, D. A., & Prather, C. P. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.025 · Cited by 1
The role of microbial translocation and gut microbiota in HIV-1 infection
Vesterbacka, J. (2017) · Figshare · Cited by 1
Villar, S. S., López‐Huertas, M. R., Jiménez, D., Galera, C., Martínez‐Sanz, J., Moreno, E., Muriel, A., Gutiérrez, F., Busca, C., Portilla, J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3976877 · Cited by 1
Giron, L. B., Peluso, M. J., Ding, J., Kenny, G., Zilberstein, N., Koshy, J., Hong, K. Y., Rasmussen, H. E., Miller, G., Bishehsari, F., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.488051 · Cited by 1
Self-citationDecreased bone turnover in HIV-infected children on antiretroviral therapy
Shiau, S. (2017) · doi:10.26226/morressier.59020064d462b80292385d45 · Cited by 1
Villar, S. S., & Moreno, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923905 · Cited by 1
Tamargo, J. A. (2021) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc009566 · Cited by 1
Teeman, C. S. (2021) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc010264 · Cited by 1
HIV Without AIDS: The Immunological Secrets of Natural Hosts
Ende, Z. S., Bonkosky, M., & Paiardini, M. (2011) · InTech eBooks · doi:10.5772/21782
Chronic immune activation and lymphocyte apoptosis during HIV-1 infection
Ruffin, N. (2012) · Figshare
An antiviral immune response turning against the host in pathogenic HIV infection.
Schuren, A. B. C. (2011) · Utrecht University Repository (Utrecht University)
Immune system modulation by infections with Helminths and HIV-1
Chachage, M. (2013) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16806
Kelesidis, T. (2013) · eScholarship (California Digital Library)
Role of cellular immune functions through the course of HIV-1 natural infection in Ugandans
Eller, M. A. (2011) · Figshare
The role of Natural Killer cells in preventing HIV-1 acquisition and controlling disease progression
Naranbhai, V. (2013) · Protocol Submission & Administration
Immune Activation in HIV-Infected Patients Treated with Different ARV Regimens
Uglietti, A., Caputo, S. L., Lauriola, M., Gennaro, M. D., Chiesa, E., Coen, M., Terzi, R., Bray, D. H., Maserati, R., Trabattoni, D., et al. (2012) · World Journal of AIDS · doi:10.4236/wja.2012.22013
Troubles cognitifs associés à l’infection VIH
Lescure, F.-X., & Moulignier, A. (2014) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2014.03.004
Asokan, M., Sachidanandam, V., Satish, K. S., & Ranga, U. (2014) · VirusDisease · doi:10.1007/s13337-014-0218-8
Cornonary Heart Disease Risk and HIV Infection: The Roles of Inflammation and Co-Morbid Disease
So‐Armah, K. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Immune Modulators of HIV Infection: The Role of Reactive Oxygen
Berrueta, L. (2012)
Schuren, A. B. C. (2011)
Cunha, J. A. C. E. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/85sb-ez30
The role of Follicular helper CD4 T cells in HIV/SIV infection
Yamamoto, T. (2012) · Uirusu · doi:10.2222/jsv.62.161
Can We Control the Progression of HIV by Monitor Markers of Microbial Translocation?
Zhang, W. J., & Guo, Z. H. (2016) · doi:10.4172/jaa.1000127
HIV infection and hypertension: Epidemiological and pathogenetic aspects
Manner, I. W. (2013) · NORA - Norwegian Open Research Archives
Human immunodeficiency virus in the elderly
Prather, C. P., & Wohl, D. A. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107294967.024
Drozd, D. R. (2015) · ResearchWorks at the University of Washington (University of Washington)
Contributions of macrophages in lymph nodes and gut mucosa to SIV disease control and progression
Swan, Z. D. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Curriu, M. (2012) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
The Role of the CD14 molecule in equine endotoxemia
da Silva, A. G. A. (2012)
Xing, Y., Shepherd, N., Lan, J., Rane, S., Gupta, S. K., Zhang, S., Dong, J., & Yu, Q. (2017) · Author eBooks
Suivi et prise en charge thérapeutique de l'infection par le virus de l'immunodéficience humaine
Palich, R., & Ghosn, J. (2016)
Seguimiento y actitud terapéutica de la infección por el virus de la inmunodeficiencia humana
Palich, R., & Ghosn, J. (2017) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(17)84248-3
HIV, Immune activation and Endothelial Damage in Malawian Adults
Kelly, C. (2017) · University of Liverpool · doi:10.17638/03006512
Mudd, J. C. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Metadata
- Authors
- Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., Neaton, J. D., Brenchley, J. M., Deeks, S. G., Sereti, I., & Douek, D. C.
- Affiliations
- UNSW Sydney (AU)
- National Institutes of Health (US)
- Virginia Commonwealth University (US)
- University of Southern Denmark (DK)
- Chulalongkorn University (TH)
- Burnet Institute (AU)
- University of Minnesota (US)
- San Francisco General Hospital (US)
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-15
- Volume
- 203
- Issue
- 6
- Pages
- 780-790
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC3071127
- OpenAlex
- W2098152094
- Cited by
- 1,106
- References
- 50
- Citations by year
- 2026: 32 · 2025: 31 · 2024: 59 · 2023: 48 · 2022: 67 · 2021: 70 · 2020: 76 · 2019: 70 · 2018: 69 · 2017: 83 · 2016: 107 · 2015: 97 · 2014: 111 · 2013: 93 · 2012: 65
- FWCI
- 37.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- National Center for Genetic Engineering and Biotechnology
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI 76174, P01AI076174)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- soluble CD14, HIV infection, mortality prediction, microbial translocation, intestinal permeability, lipopolysaccharide, endotoxin core antibody, intestinal fatty acid binding protein, cardiovascular disease, AIDS, innate immune activation, SMART trial, prognostic factors
- MeSH terms
- Adult, Cause of Death, Humans, Lipopolysaccharides, Male, Middle Aged, RNA, Viral, Biomarkers, CD4-Positive T-Lymphocytes, HIV Infections, Logistic Models, Case-Control Studies, Lipopolysaccharide Receptors, Fatty Acid-Binding Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review